It brings me great pleasure to introduce myself as the new Chief Executive Officer of Pharmaceutical Associates, Inc. (PAI). Although I just recently became the CEO of PAI in January of 2017, I have led companies in the generic pharmaceutical industry for over 20 years. I am excited about the growth potential of PAI. I am humbled as well by the responsibility I now have to grow the business. Our Chairman and owner, Steve Jenkins, has made it clear that growth is our top priority moving forward.
Founded by several pharmaceutical executives in 1968, PAI now has about 300 employees and a broad portfolio of over 60 prescription and over-the-counter products. We develop, manufacture and market these generic liquid pharmaceuticals within our state-of-the-art 300,000 SF facilities in Greenville, S.C. We are the industry leader in unit dose oral liquids, with over 50% market share, according to IMS. We serve the needs of patients in both retail pharmacies and hospitals.
Two things that I am passionate about are Innovation and Growth. Our mission at PAI is to participate in the creation of healthier lives by exceeding the expectations of those we serve with innovative treatments. We are committed to growth at PAI. The strategy to do so is to focus on 3 basic principles: Quality, Supply and Growth. By delivering quality products with constant cost competitive supply, and regularly launching new products, we will continue to grow, succeed and ultimately add value to our patients’ lives.
The path to success starts with our most important asset, our employees. We are actively growing our team and looking to hire additional talent. Take a look at our open positions in the Careers section of our website and see if there’s a fit for you or someone you know. We would love to meet you and welcome you to the wonderful city of Greenville, voted by The New York Times as one of the top 52 places to visit in 2017 and ranked #29 on US News’ list for Best Places to Live!
Thank you for your ongoing interest in PAI and for your support!
Kurt J. Orlofski, CEO